BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 30616608)

  • 21. Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery.
    van 't Sant I; van Eden WJ; Engbersen MP; Kok NFM; Woensdregt K; Lambregts DMJ; Shanmuganathan S; Beets-Tan RGH; Aalbers AGJ; Lahaye MJ
    Br J Surg; 2019 Mar; 106(4):491-498. PubMed ID: 30353920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer.
    Mikkelsen MS; Petersen LK; Blaakaer J; Marinovskij E; Rosenkilde M; Andersen G; Bouchelouche K; Iversen LH
    Eur J Surg Oncol; 2021 Aug; 47(8):2134-2141. PubMed ID: 33812768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of both PET/CT with F18-FDG and whole-body diffusion-weighted imaging in cancer screening: a preliminary report.
    Sasamori H; Uno K; Wu J
    Ann Nucl Med; 2019 Feb; 33(2):78-85. PubMed ID: 30298377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
    Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G
    Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic efficacy of whole-body diffusion-weighted imaging in the detection of tumour recurrence and metastasis by comparison with 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography or computed tomography in patients with gastrointestinal cancer.
    Gong J; Cao W; Zhang Z; Deng Y; Kang L; Zhu P; Liu Z; Zhou Z
    Gastroenterol Rep (Oxf); 2015 May; 3(2):128-35. PubMed ID: 25406465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of whole-body MRI with diffusion-weighted sequence for detection of peritoneal metastases in colorectal malignancy.
    Zhang H; Dai W; Fu C; Yan X; Stemmer A; Tong T; Cai G
    Cancer Biol Med; 2018 May; 15(2):165-170. PubMed ID: 29951340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-body MRI with diffusion-weighted imaging as an adjunct to
    Willemse JRJ; Lahaye MJ; Kok NFM; Grotenhuis BA; Aalbers AGJ; Beets GL; Rijsemus C; Maas M; van Golen LW; Beets-Tan RGH; Lambregts DMJ
    Colorectal Dis; 2024 Feb; 26(2):290-299. PubMed ID: 38145899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study.
    Han SN; Amant F; Michielsen K; De Keyzer F; Fieuws S; Van Calsteren K; Dresen RC; Gziri MM; Vandecaveye V
    Eur Radiol; 2018 May; 28(5):1862-1874. PubMed ID: 29218610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of distant metastases in rectal cancer: contrast-enhanced CT vs whole body MRI.
    Yoon JH; Yu MH; Hur BY; Park CM; Lee JM
    Eur Radiol; 2021 Jan; 31(1):104-111. PubMed ID: 32789755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
    Lopez-Lopez V; Cascales-Campos PA; Gil J; Frutos L; Andrade RJ; Fuster-Quiñonero M; Feliciangeli E; Gil E; Parrilla P
    Eur J Radiol; 2016 Oct; 85(10):1824-1828. PubMed ID: 27666623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
    Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
    J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT.
    Satoh Y; Ichikawa T; Motosugi U; Kimura K; Sou H; Sano K; Araki T
    AJR Am J Roentgenol; 2011 Feb; 196(2):447-53. PubMed ID: 21257899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer.
    Conde-Moreno AJ; Herrando-Parreño G; Muelas-Soria R; Ferrer-Rebolleda J; Broseta-Torres R; Cozar-Santiago MP; García-Piñón F; Ferrer-Albiach C
    Clin Transl Oncol; 2017 May; 19(5):553-561. PubMed ID: 27796820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative assessment of peritoneal carcinomatosis of colorectal origin.
    Dohan A; Hobeika C; Najah H; Pocard M; Rousset P; Eveno C
    J Visc Surg; 2018 Sep; 155(4):293-303. PubMed ID: 29602696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy.
    Soussan M; Des Guetz G; Barrau V; Aflalo-Hazan V; Pop G; Mehanna Z; Rust E; Aparicio T; Douard R; Benamouzig R; Wind P; Eder V
    Eur Radiol; 2012 Jul; 22(7):1479-87. PubMed ID: 22358428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D; Patti C; Lagalla R; Midiri M; Galia M
    J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of whole-body MRI including diffusion-weighted sequences in the initial staging of breast cancer patients at high risk of metastases in comparison with PET-CT: a prospective cohort study.
    Hottat NA; Badr DA; Ben Ghanem M; Besse-Hammer T; Lecomte SM; Vansteelandt C; Lecomte SL; Khaled C; De Grove V; Salem Wehbe G; Cannie MM; Jani JC
    Eur Radiol; 2024 Jan; 34(1):165-178. PubMed ID: 37555959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended abdominopelvic MRI versus CT at the time of adnexal mass characterization for assessing radiologic peritoneal cancer index (PCI) prior to cytoreductive surgery.
    Gadelhak B; Tawfik AM; Saleh GA; Batouty NM; Sobh DM; Hamdy O; Refky B
    Abdom Radiol (NY); 2019 Jun; 44(6):2254-2261. PubMed ID: 30788559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphoma.
    Balbo-Mussetto A; Saviolo C; Fornari A; Gottardi D; Petracchini M; Macera A; Lario CV; Gallo T; Tarella C; Cirillo S
    Radiol Med; 2017 Aug; 122(8):623-632. PubMed ID: 28421406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.